As of November 6, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of The Gabelli Healthcare & WellnessRx Trust. The largest reported stake is Gamco Investors, Inc. Et Al's, at 33.9%. 7 filings are on record since July 1, 2025 (Schedule 13D/A, December 29, 2025).
Who owns Gabelli Healthcare & WellnessRx Trust?
Sell to companies like The Gabelli Healthcare & WellnessRx Trust? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Saba Capital Management, L.P. · Sole voting: 0 · Shared voting: 2,155,133 · Sole dispositive: 0 · Shared dispositive: 2,155,133 · SCHEDULE 13D/A, 2026-08-28
- · Holder: Gamco Investors, Inc. Et Al · Percent: 33.9% · SCHEDULE 13D/A
- · Holder: Gamco Investors, Inc. Et Al · Percent: 40.5% · SCHEDULE 13D/A
- · Holder: Gamco Investors, Inc. Et Al · Percent: 40.5% · SCHEDULE 13D/A
- · Holder: Saba Capital Management, L.P. · Percent: 13.3% · SCHEDULE 13D/A
The Gabelli Healthcare & WellnessRx Trust has 7 Schedule 13D or 13G filings on record since 2025-07-01. 3 holders' latest filing reports 5% or more of common shares, $0.001 par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Gamco Investors, Inc. Et Al | 33.9% | 500,000 | SCHEDULE 13D/A, 2025-12-29 | 2025-12-26 |
| Saba Capital Management, L.P. | 14.32% | 2,155,133 | SCHEDULE 13D/A, 2026-08-28 | 2026-08-27 |
| Sit Investment Associates, Inc. | 5.4% | 833,756 | SCHEDULE 13G, 2025-10-02 | 2025-09-30 |
Holding shares or following this stake? See who's behind The Gabelli Healthcare & WellnessRx Trust and the warning signs.
Free to see. No signup.
Keep reading
More on The Gabelli Healthcare & WellnessRx Trust and the records around it.
The Gabelli Healthcare & WellnessRx Trust elsewhere on the record
Companies that share a holder
- GAMCO INVESTORS, INC. ET AL also filed stake reports on 45 other companies: WESTWOOD HOLDINGS GROUP INC (Nov 2026), NATHANS FAMOUS, INC. (Oct 2026), BEASLEY BROADCAST GROUP INC (Oct 2026)
- Sit Investment Associates, Inc. also filed stake reports on 67 other companies: TCW STRATEGIC INCOME FUND INC (Nov 2026), Western Asset Premier Bond Fund (Nov 2026), Blackstone Long-Short Credit Income Fund (Oct 2026)
- Saba Capital Management, L.P. also filed stake reports on 69 other companies: BlackRock TCP Capital Corp. (Nov 2026), Ellsworth Growth and Income Fund Ltd. (Nov 2026), Virtus Total Return Fund Inc. (Nov 2026)
Watch The Gabelli Healthcare & WellnessRx Trust
Get an email when The Gabelli Healthcare & WellnessRx Trust files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on The Gabelli Healthcare & WellnessRx Trust?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on The Gabelli Healthcare & WellnessRx Trust: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on The Gabelli Healthcare & WellnessRx Trust covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Saba Capital Management, L.P. | 0 | 2,155,133 | 0 | 2,155,133 | SCHEDULE 13D/A, 2026-08-28 |
| Boaz R. Weinstein | 0 | 2,155,133 | 0 | 2,155,133 | SCHEDULE 13D/A, 2026-08-28 |
| Saba Capital Management GP, LLC | 0 | 2,155,133 | 0 | 2,155,133 | SCHEDULE 13D/A, 2026-08-28 |
The latest filing identifies The Gabelli Healthcare & WellnessRx Trust by CUSIP 36246K103 and gives its principal executive office as One Corporate Center, Rye, NY 10580 (SCHEDULE 13D/A, 2026-08-28).
Source of funds (Item 3)
Funds for the purchase of the Common Shares were derived from the subscription proceeds from investors and the capital appreciation thereon and margin account borrowings made in the ordinary course of business. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Common Shares reported herein.Saba Capital Management, L.P., SCHEDULE 13D/A, 2026-08-28
Purpose of Transaction (Item 4)
Gamco Investors, Inc. Et Al
The Reporting Persons file the long form Schedule 13D pursuant to Section 13d-1 of the Securities Exchange Act of 1934 (the "Act") even though they may be technically eligible to file the short form Schedule G. Because the Reporting Persons may regularly communicate with the Issuer's management, filing the Schedule 13D ensures that these conversations are compliant with the reporting obligations under the Exchange Act.Item 4 of the SCHEDULE 13D/A filed 2025-12-29
Saba Capital Management, L.P.
Not Applicable.Item 4 of the SCHEDULE 13D/A filed 2026-08-28
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-01 | Gamco Investors, Inc. Et Al | 12% | SCHEDULE 13D/A |
| 2025-10-02 | Sit Investment Associates, Inc. | 5.4% | SCHEDULE 13G |
| 2025-10-20 | Saba Capital Management, L.P. | 13.3% | SCHEDULE 13D/A |
| 2025-10-30 | Gamco Investors, Inc. Et Al | 40.5% | SCHEDULE 13D/A |
| 2025-11-03 | Gamco Investors, Inc. Et Al | 40.5% | SCHEDULE 13D/A |
| 2025-12-29 | Gamco Investors, Inc. Et Al | 33.9% | SCHEDULE 13D/A |
| 2026-08-28 | Saba Capital Management, L.P. | 14.32% | SCHEDULE 13D/A |
Questions about who owns The Gabelli Healthcare & WellnessRx Trust
Who owns The Gabelli Healthcare & WellnessRx Trust?
On this page, 3 holders' latest ownership filings report 5% or more of The Gabelli Healthcare & WellnessRx Trust: Gamco Investors, Inc. Et Al (33.9%, Schedule 13D/A, filed 2025-12-29), Saba Capital Management, L.P. (14.32%, Schedule 13D/A, filed 2026-08-28) and Sit Investment Associates, Inc. (5.4%, Schedule 13G, filed 2025-10-02).
Who are the largest shareholders of The Gabelli Healthcare & WellnessRx Trust?
By the share each holder's latest filing reports, the largest holders of The Gabelli Healthcare & WellnessRx Trust on this page are Gamco Investors, Inc. Et Al (33.9%), Saba Capital Management, L.P. (14.32%) and Sit Investment Associates, Inc. (5.4%).
When did Gamco Investors, Inc. Et Al buy into The Gabelli Healthcare & WellnessRx Trust?
The filings give report dates, not purchase dates. The earliest filing from Gamco Investors, Inc. Et Al on this page is the Schedule 13D/A, filed 2025-07-01, reporting 12%; its latest, Schedule 13D/A filed 2025-12-29, reports 33.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for The Gabelli Healthcare & WellnessRx Trust. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.